FI840635A0 - Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel - Google Patents

Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel

Info

Publication number
FI840635A0
FI840635A0 FI840635A FI840635A FI840635A0 FI 840635 A0 FI840635 A0 FI 840635A0 FI 840635 A FI840635 A FI 840635A FI 840635 A FI840635 A FI 840635A FI 840635 A0 FI840635 A0 FI 840635A0
Authority
FI
Finland
Prior art keywords
karbacykliner
nya
foerfarande foer
foer framstaellning
och deras
Prior art date
Application number
FI840635A
Other languages
English (en)
Other versions
FI78065B (fi
FI840635A (fi
FI78065C (fi
Inventor
Werner Skuballa
Bernd Raduechel
Helmut Vorbrueggen
Claus-Steffen Stuerzebecher
Martin Haberey
Ekkehard Schillinger
Michael-Harold Town
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI840635A0 publication Critical patent/FI840635A0/fi
Publication of FI840635A publication Critical patent/FI840635A/fi
Publication of FI78065B publication Critical patent/FI78065B/fi
Application granted granted Critical
Publication of FI78065C publication Critical patent/FI78065C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Basic Packing Technique (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
FI840635A 1983-02-18 1984-02-16 Foerfarande foer framstaellning av terapeutiskt anvaendbara (5e)-13,14,18,18,19,19-hexadehydro-3-oxa-6a- karbaprostaglandin-i2-derivat. FI78065C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833306123 DE3306123A1 (de) 1983-02-18 1983-02-18 Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3306123 1983-02-18

Publications (4)

Publication Number Publication Date
FI840635A0 true FI840635A0 (fi) 1984-02-16
FI840635A FI840635A (fi) 1984-08-19
FI78065B FI78065B (fi) 1989-02-28
FI78065C FI78065C (fi) 1989-06-12

Family

ID=6191513

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840635A FI78065C (fi) 1983-02-18 1984-02-16 Foerfarande foer framstaellning av terapeutiskt anvaendbara (5e)-13,14,18,18,19,19-hexadehydro-3-oxa-6a- karbaprostaglandin-i2-derivat.

Country Status (22)

Country Link
US (1) US5013758A (fi)
EP (1) EP0119949B1 (fi)
JP (1) JPH0611726B2 (fi)
AT (1) ATE38831T1 (fi)
AU (1) AU580728B2 (fi)
CA (1) CA1251200A (fi)
CS (1) CS270552B2 (fi)
DD (1) DD216448A5 (fi)
DE (2) DE3306123A1 (fi)
DK (1) DK155828C (fi)
ES (1) ES529636A0 (fi)
FI (1) FI78065C (fi)
GR (1) GR81961B (fi)
HU (1) HU191994B (fi)
IE (1) IE56703B1 (fi)
IL (1) IL70905A (fi)
NO (1) NO157060C (fi)
NZ (1) NZ207061A (fi)
PH (1) PH21468A (fi)
SU (1) SU1384196A3 (fi)
YU (1) YU45173B (fi)
ZA (1) ZA841198B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225287A1 (de) * 1982-07-02 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Neue carbacyclinamide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3610556A1 (de) * 1986-03-26 1987-10-01 Schering Ag 7-oxoprostacyclinderivate und verfahren zu ihrer herstellung
DE3727065A1 (de) * 1987-08-11 1989-02-23 Schering Ag Verfahren zur herstellung von e/z-gemischen von 2-(bicyclo-(3.3.0)-octan-3-yliden) -essigsaeurederivaten mit ueberwiegendem e- oder z-anteil
US5169960A (en) * 1987-08-11 1992-12-08 Schering Aktiengesellschaft Process for the production of E/Z mixtures of 2-(bicyclo[3.3.0]octan-3-ylidene)-acetic acid derivatives with predominant E or Z portion
US5371284A (en) * 1987-09-03 1994-12-06 Schering Corporation Phenyl acetylenic acetals
DE3835162A1 (de) * 1988-10-13 1990-04-19 Schering Ag (1s,2s,3r,5r)-2-((3s)-2-halogen-3-hydroxy-1-alken(inyl))-3-trialkylsilyloxy-7,7-(2,2-dimethyl-trimethylendioxy)-bicyclo-(3.3.0)-octan-verbindungen und verfahren zu deren herstellung
DE3909329A1 (de) * 1989-03-17 1990-09-20 Schering Ag 20-alkyl-13,14,18,18,19,19-hexadehydro-3- oxa-isocarbacyclin-derivate und ihre pharmazeutische verwendung
DE3933523A1 (de) * 1989-10-05 1991-04-11 Schering Ag Antimetastatisch wirkende mittel
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
DE4028864A1 (de) * 1990-09-07 1992-03-12 Schering Ag Verfahren zur herstellung von e/z-mischungen von 2-(6-alkyl-bicyclo-(3.3.0)-octan-3-yliden) -essigsaeure-derivaten mit ueberwiegendem anteil des e-isomeren
EP0867185B1 (en) * 1996-09-17 2002-06-12 Toray Industries, Inc. Platelet function potentiator and method of curing platelet dysfunction
KR20070054644A (ko) * 2004-07-26 2007-05-29 액테리온 파마슈티칼 리미티드 미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료
JP5271272B2 (ja) 2006-11-16 2013-08-21 ジェンムス ファーマ インコーポレイティド Ａ型インフルエンザウィルス感染の治療のための薬剤としてのｅｐ２およびｅｐ４作動薬
WO2011047048A1 (en) 2009-10-14 2011-04-21 Gemmus Pharma, Inc. Combination therapy treatment for viral infections
TWI513462B (zh) 2009-11-13 2015-12-21 Toray Industries 糖尿病之治療或預防藥
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048906A1 (de) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3121155A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
IE56703B1 (en) 1991-11-06
AU2401584A (en) 1984-08-23
ATE38831T1 (de) 1988-12-15
IL70905A (en) 1987-02-27
DE3306123A1 (de) 1984-09-06
GR81961B (fi) 1984-12-12
IE840236L (en) 1984-08-18
YU45173B (en) 1992-05-28
EP0119949B1 (de) 1988-11-23
DK55584D0 (da) 1984-02-08
NO840595L (no) 1984-08-20
FI78065B (fi) 1989-02-28
JPS59157050A (ja) 1984-09-06
IL70905A0 (en) 1984-05-31
FI840635A (fi) 1984-08-19
FI78065C (fi) 1989-06-12
NO157060B (no) 1987-10-05
CS270552B2 (en) 1990-07-12
PH21468A (en) 1987-10-28
DK55584A (da) 1984-08-19
DD216448A5 (de) 1984-12-12
AU580728B2 (en) 1989-02-02
DK155828B (da) 1989-05-22
DE3475302D1 (en) 1988-12-29
US5013758A (en) 1991-05-07
ZA841198B (en) 1984-09-26
SU1384196A3 (ru) 1988-03-23
EP0119949A1 (de) 1984-09-26
JPH0611726B2 (ja) 1994-02-16
NZ207061A (en) 1987-06-30
DK155828C (da) 1989-10-09
YU24484A (en) 1986-06-30
ES8500209A1 (es) 1984-11-01
HU191994B (en) 1987-04-28
CA1251200A (en) 1989-03-14
ES529636A0 (es) 1984-11-01
CS103684A2 (en) 1989-11-14
NO157060C (no) 1988-01-13

Similar Documents

Publication Publication Date Title
FI840635A (fi) Nya karbacykliner, foerfarande foer framstaellning av dem och deras anvaendning som laekemedel.
NZ508918A (en) 2-(Purin-9-YL)-tetrahydrofuran-3,4-diol derivatives useful for the treatment of inflammation
IT1131887B (it) Glicosidi antraciclinici
DE3361369D1 (en) Indanyl derivatives, their preparation and their use
ES516361A0 (es) "procedimiento para la preparacion de un diisocianato".
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
ES544919A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes
AU567867B2 (en) 5(e)-13,14,18,18,19,19-hexahydro-6a-carbaprostaglandin 12 derivatives
EP0278008A4 (en) TAURINE TYPE COMPOUNDS.
ES8506035A1 (es) Procedimiento para preparar nuevas sales de bis-alquilfosfonico de n-fosfonometilglicina
TH2282EX (th) สารเฟนนิลซัลโฟนิล กวานิดีน ที่มีกลุ่มแทนที่ชนิดใหม่สำหรับปราบวัชพืชและสารรายทาง
KR830004786A (ko) 상승작용을 가진 포스피노트리신 조성물

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT